137 related articles for article (PubMed ID: 12469326)
1. Hypermethylation of gene promoters in hematological neoplasia.
Chim CS; Liang R; Kwong YL
Hematol Oncol; 2002 Dec; 20(4):167-76. PubMed ID: 12469326
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
3. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
4. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
5. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
7. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation and gene silencing in cancer: which is the guilty party?
Clark SJ; Melki J
Oncogene; 2002 Aug; 21(35):5380-7. PubMed ID: 12154400
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
10. The fundamental role of epigenetics in hematopoietic malignancies.
Galm O; Herman JG; Baylin SB
Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
13. De novo CpG island methylation in human cancer cells.
Jair KW; Bachman KE; Suzuki H; Ting AH; Rhee I; Yen RW; Baylin SB; Schuebel KE
Cancer Res; 2006 Jan; 66(2):682-92. PubMed ID: 16423997
[TBL] [Abstract][Full Text] [Related]
14. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
Jacinto FV; Ballestar E; Esteller M
Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
[TBL] [Abstract][Full Text] [Related]
15. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
[TBL] [Abstract][Full Text] [Related]
16. Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.
Dammann R; Schagdarsurengin U; Seidel C; Trümpler C; Hoang-Vu C; Gimm O; Dralle H; Pfeifer GP; Brauckhoff M
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):1-7. PubMed ID: 15662588
[TBL] [Abstract][Full Text] [Related]
17. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.
Kim H; Kwon YM; Kim JS; Han J; Shim YM; Park J; Kim DH
Cancer; 2006 Sep; 107(5):1042-9. PubMed ID: 16888795
[TBL] [Abstract][Full Text] [Related]
18. Dormant hypermethylated tumour suppressor genes: questions and answers.
Esteller M
J Pathol; 2005 Jan; 205(2):172-80. PubMed ID: 15643671
[TBL] [Abstract][Full Text] [Related]
19. [The roles of DNA methylation in human neoplasms].
Yuan YF; Li JQ; Yang ZL; Wang JP
Ai Zheng; 2002 Nov; 21(11):1267-77. PubMed ID: 12526230
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]